Abivax SA (ABVX) is listed on NASDAQ in Pharmaceutical Stocks. It is $113.32, -0.86%. RSI is 33.7, near oversold.
Technical Analysis
RSI (14) 33.7 Near Oversold
Volume 970.4K
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $534.20 | 52.0 | $12.3B |
| | $118.52 | 47.9 | $25.9B |
| | $199.01 | 34.8 | $10.4B |
| | $50.83 | 49.4 | -- |
Take ABVX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ABVX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Abivax SA next reports.
Set alerts on ABVX
Get notified when Abivax SA hits your price targets or technical conditions are met.
Get Started Free